Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Trichodysplasia spinulosa in a child: Identification of trichodysplasia spinulosa-associated polyomavirus in skin, serum, and urine.

Chamseddin BH, Tran BAPD, Lee EE, Pastrana DV, Buck CB, Wang RC, Kirkorian AY.

Pediatr Dermatol. 2019 Sep;36(5):723-724. doi: 10.1111/pde.13857. Epub 2019 Jun 12.

PMID:
31190328
2.

Plerixafor for the Treatment of WHIM Syndrome.

McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, Velez D, Cho E, Liu Q, Trout HH 3rd, Neves JF, Gardner PJ, Bianchi DA, Blair EA, Landon EM, Silva SL, Buck CB, Murphy PM.

N Engl J Med. 2019 Jan 10;380(2):163-170. doi: 10.1056/NEJMoa1808575.

3.

Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency.

Pastrana DV, Peretti A, Welch NL, Borgogna C, Olivero C, Badolato R, Notarangelo LD, Gariglio M, FitzGerald PC, McIntosh CE, Reeves J, Starrett GJ, Bliskovsky V, Velez D, Brownell I, Yarchoan R, Wyvill KM, Uldrick TS, Maldarelli F, Lisco A, Sereti I, Gonzalez CM, Androphy EJ, McBride AA, Van Doorslaer K, Garcia F, Dvoretzky I, Liu JS, Han J, Murphy PM, McDermott DH, Buck CB.

mSphere. 2018 Dec 12;3(6). pii: e00645-18. doi: 10.1128/mSphereDirect.00645-18.

4.

Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.

Wunderink HF, de Brouwer CS, van der Meijden E, Pastrana DV, Kroes ACM, Buck CB, Feltkamp MCW.

J Clin Virol. 2019 Jan;110:22-28. doi: 10.1016/j.jcv.2018.11.009. Epub 2018 Dec 1.

5.

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.

Peretti A, Geoghegan EM, Pastrana DV, Smola S, Feld P, Sauter M, Lohse S, Ramesh M, Lim ES, Wang D, Borgogna C, FitzGerald PC, Bliskovsky V, Starrett GJ, Law EK, Harris RS, Killian JK, Zhu J, Pineda M, Meltzer PS, Boldorini R, Gariglio M, Buck CB.

Cell Host Microbe. 2018 May 9;23(5):628-635.e7. doi: 10.1016/j.chom.2018.04.005.

6.

Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Geoghegan EM, Pastrana DV, Schowalter RM, Ray U, Gao W, Ho M, Pauly GT, Sigano DM, Kaynor C, Cahir-McFarland E, Combaluzier B, Grimm J, Buck CB.

Cell Rep. 2017 Oct 31;21(5):1169-1179. doi: 10.1016/j.celrep.2017.10.027.

7.

Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses.

Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, Buck CB, Wang RC.

J Am Acad Dermatol. 2017 May;76(5):932-940.e3. doi: 10.1016/j.jaad.2016.11.035. Epub 2016 Dec 29.

8.

The Ancient Evolutionary History of Polyomaviruses.

Buck CB, Van Doorslaer K, Peretti A, Geoghegan EM, Tisza MJ, An P, Katz JP, Pipas JM, McBride AA, Camus AC, McDermott AJ, Dill JA, Delwart E, Ng TF, Farkas K, Austin C, Kraberger S, Davison W, Pastrana DV, Varsani A.

PLoS Pathog. 2016 Apr 19;12(4):e1005574. doi: 10.1371/journal.ppat.1005574. eCollection 2016 Apr.

9.

Erratum for Pastrana et al., BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2015 Dec 17;90(1):624. doi: 10.1128/JVI.02585-15. Print 2016 Jan 1. No abstract available.

10.

JC polyomavirus mutants escape antibody-mediated neutralization.

Ray U, Cinque P, Gerevini S, Longo V, Lazzarin A, Schippling S, Martin R, Buck CB, Pastrana DV.

Sci Transl Med. 2015 Sep 23;7(306):306ra151. doi: 10.1126/scitranslmed.aab1720. Epub 2015 Sep 23.

11.

Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

Randhawa P, Pastrana DV, Zeng G, Huang Y, Shapiro R, Sood P, Puttarajappa C, Berger M, Hariharan S, Buck CB.

Am J Transplant. 2015 Apr;15(4):1014-20. doi: 10.1111/ajt.13083. Epub 2015 Mar 3.

12.

Genome Sequence of a Fish-Associated Polyomavirus, Black Sea Bass (Centropristis striata) Polyomavirus 1.

Peretti A, FitzGerald PC, Bliskovsky V, Pastrana DV, Buck CB.

Genome Announc. 2015 Jan 29;3(1). pii: e01476-14. doi: 10.1128/genomeA.01476-14.

13.

Hamburger polyomaviruses.

Peretti A, FitzGerald PC, Bliskovsky V, Buck CB, Pastrana DV.

J Gen Virol. 2015 Apr;96(Pt 4):833-9. doi: 10.1099/vir.0.000033. Epub 2015 Jan 7.

14.

WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome.

Siebrasse EA, Pastrana DV, Nguyen NL, Wang A, Roth MJ, Holland SM, Freeman AF, McDyer J, Buck CB, Wang D.

Emerg Infect Dis. 2015 Jan;21(1):103-6. doi: 10.3201/eid2101.140855.

15.

Detection of human polyomavirus 7 in human thymic epithelial tumors.

Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, Buck CB, De Baets MH, Zur Hausen A.

J Thorac Oncol. 2015 Feb;10(2):360-6. doi: 10.1097/JTO.0000000000000390.

16.

Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients.

Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proksell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Y.

J Infect Dis. 2015 May 15;211(10):1560-5. doi: 10.1093/infdis/jiu524. Epub 2014 Sep 17.

17.

Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.

Schrama D, Groesser L, Ugurel S, Hafner C, Pastrana DV, Buck CB, Cerroni L, Theiler A, Becker JC.

JAMA Dermatol. 2014 Nov;150(11):1180-6. doi: 10.1001/jamadermatol.2014.1116.

PMID:
24943872
18.

A divergent variant of the eleventh human polyomavirus species, saint louis polyomavirus.

Pastrana DV, Fitzgerald PC, Phan GQ, Raiji MT, Murphy PM, McDermott DH, Velez D, Bliskovsky V, McBride AA, Buck CB.

Genome Announc. 2013 Oct 24;1(5). pii: e00812-13. doi: 10.1128/genomeA.00812-13.

19.

BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism.

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB.

J Virol. 2013 Sep;87(18):10105-13. doi: 10.1128/JVI.01189-13. Epub 2013 Jul 10. Erratum in: J Virol. 2016 Jan 1;90(1):624.

20.

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.

Pastrana DV, Brennan DC, Cuburu N, Storch GA, Viscidi RP, Randhawa PS, Buck CB.

PLoS Pathog. 2012;8(4):e1002650. doi: 10.1371/journal.ppat.1002650. Epub 2012 Apr 12.

21.

Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.

Schowalter RM, Pastrana DV, Buck CB.

PLoS Pathog. 2011 Jul;7(7):e1002161. doi: 10.1371/journal.ppat.1002161. Epub 2011 Jul 28.

22.

Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer.

Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H.

Med Microbiol Immunol. 2012 Feb;201(1):17-23. doi: 10.1007/s00430-011-0200-7. Epub 2011 May 26.

23.

Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin.

Faust H, Pastrana DV, Buck CB, Dillner J, Ekström J.

J Infect Dis. 2011 Apr 15;203(8):1096-100. doi: 10.1093/infdis/jiq173.

PMID:
21450999
24.

Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid.

Pastrana DV, Pumphrey KA, Cuburu N, Schowalter RM, Buck CB.

Virology. 2010 Sep 15;405(1):20-5. doi: 10.1016/j.virol.2010.06.022. Epub 2010 Jul 3.

25.

ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol.

Traini R, Ben-Josef G, Pastrana DV, Moskatel E, Sharma AK, Antignani A, Fitzgerald DJ.

Mol Cancer Ther. 2010 Jul;9(7):2007-15. doi: 10.1158/1535-7163.MCT-10-0257. Epub 2010 Jun 29.

26.

Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin.

Schowalter RM, Pastrana DV, Pumphrey KA, Moyer AL, Buck CB.

Cell Host Microbe. 2010 Jun 25;7(6):509-15. doi: 10.1016/j.chom.2010.05.006.

27.

DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas.

Giraud G, Ramqvist T, Pastrana DV, Pavot V, Lindau C, Kogner P, Orrego A, Buck CB, Allander T, Holm S, Gustavsson B, Dalianis T.

PLoS One. 2009 Dec 11;4(12):e8239. doi: 10.1371/journal.pone.0008239.

28.

Quantitation of human seroresponsiveness to Merkel cell polyomavirus.

Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB.

PLoS Pathog. 2009 Sep;5(9):e1000578. doi: 10.1371/journal.ppat.1000578. Epub 2009 Sep 11.

29.

Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.

Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, Chang Y, Buck CB, Moore PS.

Int J Cancer. 2009 Sep 15;125(6):1250-6. doi: 10.1002/ijc.24509.

30.

Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosa.

Sarnovsky R, Rea J, Makowski M, Hertle R, Kelly C, Antignani A, Pastrana DV, Fitzgerald DJ.

J Biol Chem. 2009 Apr 10;284(15):10243-53. doi: 10.1074/jbc.M808686200. Epub 2009 Feb 11.

31.

Mammalian cell expression of an active site mutant of Pseudomonas exotoxin disrupts LRP1 maturation.

Pastrana DV, Yun CH, McKee ML, Fitzgerald DJ.

J Biomed Sci. 2008 Jul;15(4):427-39. doi: 10.1007/s11373-008-9245-z. Epub 2008 Mar 20.

PMID:
18351442
32.

A nonradioactive, cell-free method for measuring protein synthesis inhibition by Pseudomonas exotoxin.

Pastrana DV, FitzGerald DJ.

Anal Biochem. 2006 Jun 15;353(2):266-71. Epub 2006 Apr 17.

PMID:
16647035
33.

Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Buck CB, Pastrana DV, Lowy DR, Schiller JT.

Methods Mol Med. 2005;119:445-62.

PMID:
16350417
34.

LRP 1 B functions as a receptor for Pseudomonas exotoxin.

Pastrana DV, Hanson AJ, Knisely J, Bu G, Fitzgerald DJ.

Biochim Biophys Acta. 2005 Sep 25;1741(3):234-9.

35.

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.

J Virol. 2005 Jun;79(11):6741-50.

36.

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, Culp TD, Christensen ND, Lowy DR, Schiller JT, Roden RB.

Virology. 2005 Jul 5;337(2):365-72.

37.

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.

Rollman E, Arnheim L, Collier B, Oberg D, Hall H, Klingström J, Dillner J, Pastrana DV, Buck CB, Hinkula J, Wahren B, Schwartz S.

Virology. 2004 Apr 25;322(1):182-9.

38.

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Krüger Kjaer S, Lowy DR, Schiller JT.

Virology. 2004 Apr 10;321(2):205-16.

39.

Efficient intracellular assembly of papillomaviral vectors.

Buck CB, Pastrana DV, Lowy DR, Schiller JT.

J Virol. 2004 Jan;78(2):751-7.

40.
41.

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

Pastrana DV, Vass WC, Lowy DR, Schiller JT.

Virology. 2001 Jan 5;279(1):361-9.

42.

Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor.

Pastrana DV, Raghavan N, FitzGerald P, Eisinger SW, Metz C, Bucala R, Schleimer RP, Bickel C, Scott AL.

Infect Immun. 1998 Dec;66(12):5955-63.

Supplemental Content

Loading ...
Support Center